Gene · 3416
Papers2,652
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,652
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Knowledge-map and bibliometric analysis of scientific research on FDA-approved Chimeric Antigen Receptor T cell products (2015-2024). | Discov Oncol | 2025 | 40754556 | PubTator, text mining | PubMed |
| Understanding the Insulin-Degrading Enzyme: A New Look at Alzheimer's Disease and Aβ Plaque Management. | Int J Mol Sci | 2025 | 40724942 | PubTator, text mining | PubMed |
| Insulin-Degrading Enzyme Regulates mRNA Processing and May Interact with the CCR4-NOT Complex. | Cells | 2025 | 40497968 | PubTator, text mining | PubMed |
| Unraveling novel mechanisms of ATP-Binding cassette (ABC) transporter in insulin Resistance-induced amyloidogenesis. | Metab Brain Dis | 2025 | 40482009 | PubTator, text mining | PubMed |
| Evidence for Dark Energy Driven by Star Formation: Information Dark Energy? | Entropy (Basel) | 2025 | 40003107 | PubTator, text mining | PubMed |
| Nano-Collision Electrochemistry for Real-Time Monitoring of Amyloid-β Oligomerization and Rapid Screening of Degrading Drugs. | Anal Chem | 2025 | 39992990 | PubTator, text mining | PubMed |
| Krüppel-like factor 9 alleviates Alzheimer's disease via IDE-mediated Aβ degradation. | Acta Pharmacol Sin | 2025 | 39962264 | PubTator, text mining | PubMed |
| Succinylation enables IDE to act as a hub of larval tissue destruction and adult tissue reconstruction during insect metamorphosis. | Sci Adv | 2025 | 39908369 | PubTator, text mining | PubMed |
| Ide Copy Number Variant Does Not Influence Stroke Severity in 2 C57BL/6J Mouse Models nor in Humans: An Exploratory Study. | Stroke | 2025 | 39866114 | PubTator, text mining | PubMed |
| Characterization and modulation of human insulin degrading enzyme conformational dynamics to control enzyme activity. | bioRxiv | 2025 | 39803525 | PubTator, text mining | PubMed |
| Flavin mononucleotide, a potent inhibitor of insulin-degrading enzyme: an in-silico study. | J Biomol Struct Dyn | 2025 | 39659241 | PubTator, text mining | PubMed |
WuYou decoction effectively reduces neuronal damage, synaptic dysfunction, and Aβ production in rats exposed to chronic sleep deprivation by modulating the Aβ-related enzymes and SIRT1/Nrf2/NF-κB pathway. | J Ethnopharmacol | 2025 | 39413939 | PubTator, text mining | PubMed |
| On electrostatic interactions of adenosine triphosphate-insulin-degrading enzyme revealed by quantum mechanics/molecular mechanics and molecular dynamics. | Quant Biol | 2024 | 41674878 | PubTator, text mining | PubMed |
| Multicopy subtelomeric genes underlie animal infectivity of divergent Cryptosporidium hominis subtypes. | Nat Commun | 2024 | 39737947 | PubTator, text mining | PubMed |
| Combined training and hormones/enzymes with insulinotropic actions in individuals with overweight and type 2 diabetes mellitus: A randomized controlled trial. | Eur J Sport Sci | 2024 | 39661009 | PubTator, text mining | PubMed |
| Uses of Molecular Docking Simulations in Elucidating Synergistic, Additive, and/or Multi-Target (SAM) Effects of Herbal Medicines. | Molecules | 2024 | 39598795 | PubTator, text mining | PubMed |
| Case report: Double mutations in a patient with early-onset Alzheimer's disease in China, PSEN2 and IDE variants. | Front Neurosci | 2024 | 39539495 | PubTator, text mining | PubMed |
| Tyrosine modifications of insulin-degrading enzyme enable favorable control of substrate specificity for both Alzheimer's disease and type-2 diabetes mellitus. | Bioorg Chem | 2024 | 39481143 | PubTator, text mining | PubMed |
| PFOS sub-chronic exposure selectively activates Aβ clearance pathway to improve the cognitive ability of AD mice. | Environ Pollut | 2024 | 39454812 | PubTator, text mining | PubMed |
| Investigation of amyloid‑β peptide production and clearance pathways in different stages of Alzheimer's disease. | Acta Neurobiol Exp (Wars) | 2024 | 39392026 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3416/papers?page=3